Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Fungizone 50mg pdr for concentrate for inf vials
0502030A0BCAAAA
|
Fungizone | Amphotericin | Infections | 4 |
|
Gentamicin 20mg/2ml solution for injection ampoules
0501040H0AABBBB
|
Gentamicin sulfate (Systemic) | Gentamicin sulfate | Infections | 4 |
|
Keflex 500mg tablets
0501021L0BCADAH
|
Keflex | Cefalexin | Infections | 4 |
|
Meronem 500mg powder for solution for injection vials
0501022A0BBAAAA
|
Meronem | Meropenem | Infections | 4 |
|
Tenofovir alafenamide 25mg tablets
0503031D0AAAAAA
|
Tenofovir alafenamide | Tenofovir alafenamide | Infections | 4 |
|
Tobramycin 40mg/1ml solution for injection vials
0501040U0AAABAB
|
Tobramycin (Systemic) | Tobramycin | Infections | 4 |
|
Vancomycin 50mg/5ml oral solution
0501070U0AAAHAH
|
Vancomycin hydrochloride (Systemic) | Vancomycin hydrochloride | Infections | 4 |
|
Ampicillin 250mg/5ml oral suspension
0501013E0AAAFAF
|
Ampicillin | Ampicillin | Infections | 3 |
|
Aztreonam 75mg neb soln vials with device
0501023A0AAAFAF
|
Aztreonam | Aztreonam | Infections | 3 |
|
Baraclude 1mg tablets
0503031B0BBABAB
|
Baraclude | Entecavir | Infections | 3 |
|
Cefotaxime 1g powder for solution for injection vials
0501021D0AAABAB
|
Cefotaxime sodium | Cefotaxime sodium | Infections | 3 |
|
Colistimethate 1,662,500unit inhalation powder capsules
0501070I0AAAGAG
|
Colistimeth sodium (Systemic) | Colistimethate sodium | Infections | 3 |
|
Dalacin C 75mg capsules
0501060D0BBAAAA
|
Dalacin C | Clindamycin hydrochloride | Infections | 3 |
|
Doxycycline 100mg tablets
0501030I0AAALAL
|
Doxycycline hyclate (Antibacterial) | Doxycycline hyclate | Infections | 3 |
|
Efavirenz 600mg / Emtr 200mg /Tenofovir disoproxil 245mg tab
0503010ANAAAAAA
|
Efavirenz/emtricitabine/tenofovir disoproxil | Efavirenz/emtricitabine/tenofovir disoproxil | Infections | 3 |
|
Flagyl 1g suppositories
0501110C0BCAEAH
|
Flagyl | Metronidazole | Infections | 3 |
|
Genvoya 150mg/150mg/200mg/10mg tablets
050301000BBAEA0
|
Proprietary compound preparation BNF 0503010 | Other HIV infection preparations | Infections | 3 |
|
Keflex 250mg tablets
0501021L0BCACAG
|
Keflex | Cefalexin | Infections | 3 |
|
Klaricid Adult 250mg granules sachets
0501050B0BBAFAF
|
Klaricid | Clarithromycin | Infections | 3 |
|
Lamivudine 150mg tablets
0503010Q0AAAAAA
|
Lamivudine | Lamivudine | Infections | 3 |
|
Metronidazole 200mg/5ml oral solution
0501110C0AABQBQ
|
Metronidazole (Systemic) | Metronidazole | Infections | 3 |
|
Mycobutin 150mg capsules
0501090Q0BBAAAB
|
Mycobutin | Rifabutin | Infections | 3 |
|
Paromomycin 250mg tablets
0504050T0AAAEAE
|
Paromomycin sulfate | Paromomycin sulfate | Infections | 3 |
|
Ribavirin 200mg capsules
0503050B0AAABAB
|
Ribavirin | Ribavirin | Infections | 3 |
|
Ritonavir 100mg tablets
0503010U0AAACAC
|
Ritonavir | Ritonavir | Infections | 3 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.